Published in Vaccine Weekly, July 25th, 2001
S.O. Hatic and colleagues, described the usefulness of cholera toxin as a mucosal adjuvant when coadministered with antigens and the current work on generating CT chimeras with reduced toxicity and better efficiency, in their paper in the journal Analytical Biochemistry.
"To date, chimeric forms of CT [cholera toxin] have been produced in bacterial strains by co-expressing the CT B subunit and a chimeric form...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.